Evaluation of APTIMA Combo 2 for cross-reactivity with oropharyngeal Neisseria species and other microorganisms

Clinica Chimica Acta

Volumn 411, Issue 9-10, 2010, Pages 776-778

  Nagasawa, Zenzo ^a   Ikeda Dantsuji, Yurika ^b   Niwa, Toshihiro ^c   Miyakoshi, Hideo ^c   Nagayama, Ariaki ^b  

^a SAGA UNIVERSITY HOSPITAL   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c FUJIREBIO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CROSS REACTION; CULTURE MEDIUM; INCUBATION TIME; LETTER; MICROBIOLOGICAL EXAMINATION; NEISSERIA; NEISSERIA CINEREA; NEISSERIA GONORRHOEAE; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; NEISSERIA MUCOSA; NEISSERIA SUBFLAVA; NONHUMAN; NOSE CAVITY; NUCLEIC ACID AMPLIFICATION; OROPHARYNX; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS SANGUINIS; THROAT CULTURE;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; GONORRHEA; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NASAL CAVITY; NEISSERIA; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OROPHARYNX; RNA, BACTERIAL; RNA, RIBOSOMAL; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

NEISSERIA;

EID: 77950460486     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.01.039     Document Type: Letter

References (18)

1. Morris S.R., Klausner J.D., Buchbinder S.P., Wheeler S.L., Koblin B., Coates T., et al. Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin. Infect. Dis. 2006, 43:1284-1289.
2. Homma T., Ono-Kihara M., Zamani S., Nishimura Y.H., Kobori E., Hidaka Y., et al. Demographic and behavioral characteristics of male sexually transmitted disease patients in Japan: a nationwide case-control study. Sex. Transm. Dis. 2008, 35:990-996.
3. Hutt D.M., Judson F.N. Epidemiology and treatment of oropharyngeal gonorrhea. Ann. Intern. Med. 1986, 104:655-658.
4. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections-2002 MMWR. Morb. Mortal. Wkly Rep. 2002, 51:1-38. Center for Disease Control and Prevention.
5. Lowe P., O'Loughlin P., Evans K., White M., Bartley P.B., Vohra R. Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women. J. Clin. Microbiol. 2006, 44:2619-2621.
6. Moncada J., Donegan E., Schachter J. Evaluation of CDC-recommended approaches for confirmatory testing of positive Neisseria gonorrhoeae nucleic acid amplification test results. J. Clin. Microbiol. 2008, 46:1614-1619.
7. Schachter J., Moncada J., Liska S., Shayevich C., Klausner J.D. Nucleic acid amplification tests in the diagnosis of Chlamydial and Gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex. Transm. Dis. 2008, 35:637-642.
8. Knapp J.S., Hook E.W. Prevalence and persistence of Neisseria cinerea and other Neisseria spp. in adults. J. Clin. Microbiol. 1988, 26:896-900.
9. van der Pol B., Martin D.H., Schachter J., Quinn T.C., Gaydos C.A., Jones R.B., et al. Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J. Clin. Microbiol. 2001, 39:3092-3098.
10. Bachmann L.H., Johnson R.E., Cheng H., Markowitz L.E., Papp J.R., Hook E.W. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections. J. Clin. Microbiol. 2009, 47:902-907.
11. Whiley D.M., Tapsall J.W., Sloots T.P. Nucleic acid amplification testing for Neisseria gonorrhoeae. J. Mol. Diagn. 2006, 8:3-15.
12. Gaydos C.A., Quinn T.C., Willis D., Weissfeld A., Hook E.W., Martin D.H., et al. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J. Clin. Microbiol. 2003, 41:304-309.
13. Bott M., Bixby T., Castillo M., Light J., Smith M., Spencer-Covill S., et al. APTIMA Combo 2 analytical performance with C. trachomatis (CT) and N. gonorrhoease (GC). Internatl. Congress of Sex. Transm. Infections ISSTDR/IUSTI 2001 2001, 55-60. Monduzzi Editore. J.S.J. Kohl PK (Ed.).
14. Ikeda-Dantsuji Y., Konomi I., Nagayama A. In vitro assessment of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis using highly purified elementary bodies. J Med Microbiol 2005, 54:357-360.
15. Palmer H.M., Mallinson H., Wood R.L., Herring A.J. Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae. J. Clin. Microbiol. 2003, 41:835-837.
16. Ripa T., Nilsson P.A. A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests. Sex. Transm. Dis. 2007, 34:255-256.
17. Moller J.K., Pedersen L.N., Persson K. Comparison of Gen-Probe transcription-mediated amplification, Abbott PCR, and Roche PCR assays for detection of wild-type and mutant plasmid strains of Chlamydia trachomatis in Sweden. J. Clin. Microbiol. 2008, 46:3892-3895.
18. Barlow D. The diagnosis of oropharyngeal gonorrhoea. Genitourin. Med. 1997, 73:16-17.